Comparing the current results to its competitors, Axonics Inc reported Revenue increase in the 3 quarter 2024 by 25.57 % year on year. The sales growth was above Axonics Inc 's competitors' average revenue growth of 8.35 %, achieved in the same quarter.
May 17, 2024
Axonics Receives Regulatory Approval for Game-Changing Sacral Neuromodulation System in AustraliaIn a groundbreaking move for the medical field, Axonics, Inc. has announced that its recharge-free sacral neuromodulation (SNM) system has received regulatory approval from the Therapeutic Goods Administration (TGA) in Australia. This approval marks a significant breakthrough in the treatment of overactive bladder in adults, providing relief for Australians suffering from bladder and bowel dysfunction.The Axonics F15 system is a revolutionary device that offers a long-lasting solution for individuals struggling with overactive bladder. Unlike traditional SNM systems, which require frequent battery replacements, t...
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Clearpoint Neuro Inc's business model revolves around providing advanced deep brain stimulation (DBS) solutions for the treatment of neurological disorders. It focuses on developing and commercializing innovative medical devices, software, and services that enable precise and accurate targeting for electrode placement during neurosurgical procedures.
Electrocore Inc operates on a business model that focuses on developing and commercializing innovative neuromodulation therapies. They utilize non-invasive vagus nerve stimulation (nVNS) to offer patients drug-free solutions for various medical conditions. The company's approach involves leveraging their understanding of the human body's electrochemical signaling system to provide targeted and effective treatments across multiple therapeutic areas.
Inspire Medical Systems Inc operates on a direct-to-patient business model, focused on developing and commercializing innovative medical devices for patients suffering from sleep apnea. The company's business model revolves around providing a unique therapy solution through the development of its proprietary Inspire therapy system, which includes a surgically implanted device that stimulates the upper airway during sleep. By targeting both physicians and patients, Inspire Medical Systems aims to improve clinical outcomes and bring relief to those with unmet needs in the field of sleep apnea treatment.
Medtronic Plc operates a global business model centered on the development and distribution of advanced medical technologies across four key segments: Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. The company emphasizes innovation and collaboration with healthcare providers to enhance patient outcomes and drive efficiency within healthcare systems.
Sources:
Axonics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Axonics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
